Insider plans sale of 1,052 shares of common stock

An existing holder has filed a notice of proposed sale for 1,052 shares of the issuer’s common stock through a broker, with an approximate sale date of January 13, 2026.

Rhea-AI Filing Summary

An existing holder has filed a notice of proposed sale for 1,052 shares of the issuer’s common stock through a broker, with an approximate sale date of January 13, 2026.

The shares, which have an aggregate market value of $98,435.64, are to be sold on NASDAQ and will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services in New York. The securities to be sold come from equity awards acquired on March 15, 2025, consisting of 1,035 restricted stock units and 17 performance stock units granted by the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares are covered by this Form 144 filing for OKTA?

The notice covers the proposed sale of 1,052 shares of the issuer’s common stock, as listed in the securities information section.

What is the aggregate market value of the shares to be sold under this Form 144?

The 1,052 common shares to be sold have an aggregate market value of $98,435.64 according to the filing.

On which exchange will the 1,052 common shares be sold?

The filing states that the 1,052 common shares are expected to be sold on the NASDAQ securities exchange.

When were the securities being sold acquired by the selling holder?

The underlying equity awards were acquired on March 15, 2025, including restricted stock units and performance stock units granted by the issuer.

What types of equity awards are the source of the shares in this Form 144?

The securities to be sold were obtained from 1,035 restricted stock units and 17 performance stock units granted by the issuer on March 15, 2025.

Which broker is handling the proposed sale of shares disclosed in this Form 144?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

How many shares of the issuer’s common stock are outstanding, according to the Form 144?

The filing reports that there are 169,459,250 shares of the issuer’s common stock outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/13/2026 - 04:22 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001940985
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OKTA, INC
SEC File Number	001-38044
Address of Issuer	100 First Street, Suite 600 San Francisco CALIFORNIA 94105
Phone	8887227871
Name of Person for Whose Account the Securities are To Be Sold	SHIBU NINAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1052	98435.64	169459250	01/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2025	Restricted Stock Units	Issuer			1035	03/15/2025	N/A
Common	03/15/2025	Performance Stock Units	Issuer			17	03/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Shibu Ninan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)